Day One Biopharmaceuticals, Inc. Board of Directors

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Mr. Adam Dubow J.D.

Mr. Adam Dubow J.D.

General Counsel and Chief Compliance Officer

Ms. Lauren Merendino M.B.A.

Ms. Lauren Merendino M.B.A.

Chief Commercial Officer

Ms. Jaa Roberson

Ms. Jaa Roberson

Chief People Officer

Dr. Elly Barry M.D.

Dr. Elly Barry M.D.

Chief Medical Officer

Mr. John Stubenrauch Ph.D.

Mr. John Stubenrauch Ph.D.

Chief Technology Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.